Conning Inc’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $302K | Sell |
1,031
-153
| -13% | -$50.3K | 0.01% | 259 |
|
|
2025
Q4 | $415K | Sell |
1,184
-143
| -11% | -$48.3K | 0.01% | 243 |
|
|
2025
Q3 | $429K | Hold |
1,327
| – | – | 0.01% | 252 |
|
|
2025
Q2 | $516K | Sell |
1,327
-28
| -2% | -$11.3K | 0.02% | 225 |
|
|
2025
Q1 | $589K | Sell |
1,355
-46
| -3% | -$18.5K | 0.02% | 209 |
|
|
2024
Q4 | $517K | Sell |
1,401
-347
| -20% | -$145K | 0.02% | 225 |
|
|
2024
Q3 | $909K | Sell |
1,748
-25
| -1% | -$13.4K | 0.03% | 184 |
|
|
2024
Q2 | $961K | Buy |
1,773
+71
| +4% | +$37.5K | 0.03% | 175 |
|
|
2024
Q1 | $883K | Sell |
1,702
-43
| -2% | -$21.4K | 0.03% | 186 |
|
|
2023
Q4 | $823K | Sell |
1,745
-10
| -0.6% | -$4.62K | 0.03% | 185 |
|
|
2023
Q3 | $764K | Buy |
1,755
+25
| +1% | +$11.3K | 0.03% | 180 |
|
|
2023
Q2 | $769K | Sell |
1,730
-500
| -22% | -$231K | 0.03% | 192 |
|
|
2023
Q1 | $1.03M | Sell |
2,230
-91
| -4% | -$43.3K | 0.03% | 186 |
|
|
2022
Q4 | $1.19M | Sell |
2,321
-9
| -0.4% | -$4.57K | 0.04% | 188 |
|
|
2022
Q3 | $1.06M | Sell |
2,330
-256
| -10% | -$122K | 0.04% | 179 |
|
|
2022
Q2 | $1.25M | Sell |
2,586
-12
| -0.5% | -$5.94K | 0.04% | 180 |
|
|
2022
Q1 | $1.28M | Buy |
2,598
+10
| +0.4% | +$4.57K | 0.03% | 185 |
|
|
2021
Q4 | $1.2M | Sell |
2,588
-169
| -6% | -$71.1K | 0.03% | 180 |
|
|
2021
Q3 | $1.03M | Sell |
2,757
-180
| -6% | -$68.4K | 0.03% | 191 |
|
|
2021
Q2 | $1.12M | Sell |
2,937
-439
| -13% | -$168K | 0.03% | 181 |
|
|
2021
Q1 | $1.21M | Sell |
3,376
-305
| -8% | -$98.1K | 0.04% | 177 |
|
|
2020
Q4 | $1.18M | Sell |
3,681
-120
| -3% | -$36.8K | 0.04% | 179 |
|
|
2020
Q3 | $1.02M | Buy |
3,801
+45
| +1% | +$12.1K | 0.04% | 178 |
|
|
2020
Q2 | $988K | Sell |
3,756
-268
| -7% | -$71.5K | 0.04% | 179 |
|
|
2020
Q1 | $914K | Buy |
4,024
+15
| +0.4% | +$4.09K | 0.04% | 184 |
|
|
2019
Q4 | $1.21M | Sell |
4,009
-240
| -6% | -$66K | 0.04% | 185 |
|
|
2019
Q3 | $1.02M | Sell |
4,249
-50
| -1% | -$13.7K | 0.04% | 213 |
|
|
2019
Q2 | $1.21M | Sell |
4,299
-9,262
| -68% | -$2.53M | 0.04% | 198 |
|
|
2019
Q1 | $3.89M | Sell |
13,561
-30
| -0.2% | -$8.68K | 0.12% | 118 |
|
|
2018
Q4 | $3.57M | Sell |
13,591
-430
| -3% | -$118K | 0.12% | 114 |
|
|
2018
Q3 | $3.84M | Sell |
14,021
-525
| -4% | -$136K | 0.11% | 121 |
|
|
2018
Q2 | $3.46M | Sell |
14,546
-240
| -2% | -$55.6K | 0.11% | 135 |
|
|
2018
Q1 | $3.25M | Sell |
14,786
-4,950
| -25% | -$1.16M | 0.1% | 131 |
|
|
2017
Q4 | $4.44M | Sell |
19,736
-90
| -0.5% | -$19.2K | 0.15% | 116 |
|
|
2017
Q3 | $3.77M | Sell |
19,826
-110
| -0.6% | -$20.9K | 0.13% | 128 |
|
|
2017
Q2 | $3.75M | Sell |
19,936
-20
| -0.1% | -$3.59K | 0.14% | 129 |
|
|
2017
Q1 | $3.3M | Sell |
19,956
-130
| -0.6% | -$20.7K | 0.12% | 135 |
|
|
2016
Q4 | $2.89M | Buy |
20,086
+180
| +0.9% | +$24.1K | 0.12% | 141 |
|
|
2016
Q3 | $2.49M | Sell |
19,906
-20
| -0.1% | -$2.58K | 0.1% | 156 |
|
|
2016
Q2 | $2.62M | Hold |
19,926
| – | – | 0.11% | 150 |
|
|
2016
Q1 | $2.77M | Buy |
19,926
+10
| +0.1% | +$1.34K | 0.12% | 142 |
|
|
2015
Q4 | $2.78M | Sell |
19,916
-350
| -2% | -$48.2K | 0.12% | 147 |
|
|
2015
Q3 | $2.84M | Sell |
20,266
-710
| -3% | -$107K | 0.12% | 135 |
|
|
2015
Q2 | $3.44M | Sell |
20,976
-80
| -0.4% | -$12.8K | 0.14% | 127 |
|
|
2015
Q1 | $3.25M | Sell |
21,056
-100
| -0.5% | -$14.2K | 0.14% | 113 |
|
|
2014
Q4 | $2.66M | Sell |
21,156
-300
| -1% | -$37.1K | 0.13% | 126 |
|
|
2014
Q3 | $2.57M | Sell |
21,456
-730
| -3% | -$83.7K | 0.13% | 122 |
|
|
2014
Q2 | $2.39M | Sell |
22,186
-760
| -3% | -$78.3K | 0.13% | 127 |
|
|
2014
Q1 | $2.28M | Buy |
22,946
+450
| +2% | +$40.7K | 0.13% | 126 |
|
|
2013
Q4 | $2.08M | Buy |
22,496
+1,520
| +7% | +$135K | 0.13% | 127 |
|
|
2013
Q3 | $1.75M | Sell |
20,976
-20
| -0.1% | -$1.71K | 0.14% | 130 |
|
|
2013
Q2 | $1.72M | Buy |
+20,996
| New | +$1.57M | 0.14% | 128 |
|
Other funds holding ELV
VCM
VPM
Conning Inc's ELV Position: Q1 2026 in Review
Conning Inc reduced its Elevance Health (ELV) stake by 13% in Q1 2026, selling an estimated $50.3K and leaving 1,031 shares worth $302K. The position accounts for 0.01% of the portfolio, ranked #259.
Conning Inc first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.44M in Q4 2017. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Conning Inc held 1,031 shares of Elevance Health worth $302K as of Q1 2026.
- Conning Inc sold 153 Elevance Health shares in Q1 2026, an estimated $50.3K.
- Elevance Health made up 0.01% of Conning Inc's portfolio in Q1 2026, its #259 holding.
- Conning Inc first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Conning Inc's Elevance Health position peaked at $4.44M in Q4 2017.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.